“If we had clinic-ready antivirals suitable for SARS-CoV-2 when the pandemic struck in late 2019, we could have perhaps saved millions of lives,” Ben Perry A bid to discover and develop accessible and affordable oral antivirals to combat outbreaks of COVID-19 and future pandemics has received an initial award of $68 million from the US National Institutes of Health (NIH) that will fund the first three-years of a five-year project to produce preclinical candidates against six viral targets. Click to read more.
The University of Minnesota has received $66 million from the National Institute of Allergy and Infectious Diseases to establish a center to develop antiviral drugs for pandemic-level viruses, including SARS-CoV-2.
PostEra spearheads AI-driven drug discovery collaboration to develop antiviral therapeutics with initial $68M in NIH funding – Padovanews padovanews.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from padovanews.it Daily Mail and Mail on Sunday newspapers.